A carregar...
New developments in the treatment of drug-resistant tuberculosis: clinical utility of bedaquiline and delamanid
The current treatment for drug-resistant tuberculosis (TB) is long, complex, and associated with severe and life-threatening side effects and poor outcomes. For the first time in nearly 50 years, there have been two new drugs registered for use in multidrug-resistant TB (MDR-TB). Bedaquiline, a diar...
Na minha lista:
| Publicado no: | Infect Drug Resist |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4634826/ https://ncbi.nlm.nih.gov/pubmed/26586956 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S68351 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|